Clinical Trials Directory

Trials / Completed

CompletedNCT04215640

Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
136 (actual)
Sponsor
Yong Seog Oh · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

Paroxysmal supraventricular tachycardia is treated with radiofrequency ablation recently. This procedure is performed by ablating slow pathway or accessory pathway using radiofrequency ablation catheter. Recently developed mirofidelity (MIFI) catheter has mini-electrodes that can record local eletrogram with higher resolution. We aimed to investigate the efficacy of MIFI catheter in the ablation of paroxysmal supraventricular tachycardia compared to conventional radiofrequency ablation catheter. Enrolled patients undergo conventional electrophysiologic study. Patients with sustained supraventricular tachycardia during the study are randomized to either study group or control group. Radiofrequency ablation is performed using MIFI catheter in the study group, and conventional catheter (Blazer II) in the control group. The study endpoints are recorded immediately after ablation and there is no additional follow up or management after procedure.

Conditions

Interventions

TypeNameDescription
DEVICEMicrofidelity (MIFI) catheterPatients are randomized into the MIFI group and control group. Radiofrequency ablation will target slow pathway for AVNRT or accessory pathway for AVRT. Microfidelity (MIFI) catheter equipped with mini-electrodes will be used for ablation in the MIFI group.
DEVICEConventional ablation catheterPatients are randomized into the MIFI group and control group. Radiofrequency ablation will target slow pathway for AVNRT or accessory pathway for AVRT. Blazer II radiofrequency ablation catheter will be used for ablation in the control group.

Timeline

Start date
2020-01-13
Primary completion
2021-11-01
Completion
2021-11-01
First posted
2020-01-02
Last updated
2021-11-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04215640. Inclusion in this directory is not an endorsement.